Skip to content

Upper Endoscopy in Ulcerative Colitis Patients in Assiut University

Evaluation of Upper Gastrointestinal Tract Lesions in Ulcerative Colitis Patients in Assiut University

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06092593
Enrollment
70
Registered
2023-10-23
Start date
2024-01-01
Completion date
2025-10-31
Last updated
2023-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper Gastrointestinal Disorder

Brief summary

Aim of study: Primary Outcomes: Patients with ulcerative colitis-associated upper gas- trointestinal inflammation may require specific treat- ment for the gastroduodenal lesions. Hence, recogni- tion and detection of the upper gastrointestinal lesions are important. Here we describe 2 cases of ulcerative colitis and summarize the results of our investigation of the prevalence of upper gastrointestinal involvement detected by esophagogastroduodenoscopy. We also analyzed the macroscopic and microscopic features of the upper gastrointestinal lesions Secondary Outcomes: correct and timely treatment of upprt GIT lesions in UC .

Detailed description

Ulcerative colitis (UC) is an idiopathic, chronic, relapsing inflammatory bowel disease (IBD) occurring in the colon and rectum . The main typical symptoms of UC include frequent bowel movement, mucus pus, bloody diarrhea, abdominal pain and discomfort, urgency, weight loss, and tenesmus . Apart from these typical symptoms, emerging evidence supports that there are a variety of accompanying symptoms involving the upper gastrointestinal (UGI) tract in patients with UC upon macroscopic and microscopic analyses, such as eosinophilic esophagitis\[9\], gastroduodenitis, ulcers, or UGI inflammation In addition, the positive rate of UGI endoscopy in asymptomatic individuals was lower than that in symptomatic patients. The reported clinically significant UGI lesions include multiple erosions, granular changes, white spots, friable mucosa, ulcer, and purulent deposits during fibrogastroduodenoscopy (FGDS)\[ط UGI involvement may be unnoticed by the attending physician due to the lack of the knowledge of gastroduodenal lesions, which should raise concerns during UC treatment. Furthermore, there is no established standard or criteria available for patients with UC who should undergo FGDS , because the clinical backgrounds of these patients with UC-associated UGI lesions have not been fully and exactly demonstrated. Specific management may be required for patients with UC-associated UGI lesions. Henceforth, we conducted this study with the aim of describing various UGI tract presentations in UC and their differential diagnosis

Interventions

DEVICEUpper endoscopy

Evaluation of upper gastrointestinal tract lesions in ulcerative colitis patients

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years

Inclusion criteria

* Patients' age is 18 years or above. * Patient who are diagnosed with UC.. * Patient who are fit to undergo upper endoscopy .

Exclusion criteria

* Pediatric patients. * patient refuse to participate at this study * patient with known upper GIT disorder .

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of upper gastrointestinal tract lesions in ulcerative colitis patientsBaselineThe relationship between ulcerative colitis patients and upper gastrointestinal tract lesions

Contacts

Primary ContactGamal A Gaber, Master
gmalabnaser96@gmail.com01126526545
Backup ContactMuhammad Abass el masry, Professor
masaeed2@yahoo.com+20 121 240 1707

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026